Simplify 2025 Cardiology Coding with Expert Tips for Ultimate Success

Simplify 2025 Cardiology Coding with Expert Tips for Ultimate Success

In 2025, Category III codes 0913T and 0914T were introduced to streamline the reporting of percutaneous coronary interventions (PCI) by combining drug-coated balloon (DCB) angioplasty with advanced imaging techniques like intravascular ultrasound (IVUS) or optical coherence tomography (OCT). DCB angioplasty is a minimally invasive technique delivering antiproliferative drugs directly to narrowed or blocked arteries, promoting long-term vessel patency without permanent implants. These new codes reflect the growing role of innovative, precise therapies in coronary artery disease (CAD) management, ensuring accurate documentation and facilitating optimal reimbursement. Understanding key nuances is critical for correct and compliant coding come 2025. Let’s examine the details to score success now and throughout the new year.

Critical Understanding of Coronary Intervention via Drug Delivery Balloon

First, we need to understand what makes each code selection unique. Let’s start with Code 0913T. Code 0931T details PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed, on a major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).

0913TPercutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting), including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch

Code 0914T, however,  is an add-on code.  This code encompasses PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed. It is important to note this add-on code is reported when performed on a separate target lesion in addition to the primary intervention in the same major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).

+0914TPercutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting) performed on a separate target lesion from the target lesion treated with balloon angioplasty, coronary stent placement or coronary atherectomy, including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch (List separately in addition to code for percutaneous coronary stent or atherectomy intervention)

For accurate coding, coders must hold a clear understanding of the procedure itself. Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-coated balloon (DCB) is a minimally invasive procedure used to treat coronary artery disease (CAD). It involves using a specialized balloon catheter to deliver antiproliferative drugs directly to the site of a narrowed or blocked coronary artery during percutaneous coronary interventions (PCI). This approach can be combined with other interventions aimed at restoring blood flow to the heart. DCBs provide long-term vessel patency and may offer comparable outcomes to drug-eluting stents (DES) without the need for permanent implants, making them a valuable option, particularly for in-stent restenosis cases.

Exclusive Expert Coding Tips
  • Code 0913T includes the work of accessing and selectively catheterizing the vessel, coronary angiography, and intracoronary imaging (i.e., intracoronary ultrasound, intracoronary optical coherence tomography) to guide the intervention, traversing the lesion, radiological supervision and interpretation relating directly to the intervention(s) performed, closure of the arteriotomy when performed through the access sheath, and imaging performed to document completion of the intervention in addition to the intervention(s) performed.
  • Code 0914T is an add-on code and includes only the coronary angiography and intracoronary imaging (i.e., intracoronary ultrasound, intracoronary optical coherence tomography) to guide the additional intervention, traversing the additional lesion, and radiological supervision and interpretation directly related to the intervention(s) performed on the additional lesion.
  • Codes 0913T and 0914T include mechanical dilation by non-drug delivery balloon angioplasty followed by therapeutic drug delivery by drug delivery balloon.
  • Code 0913T may not be reported with codes 92920, 92924, 92928, 92933, 92941, 92943, 92973, or 92978 for percutaneous coronary interventions on the same target lesion in the same major coronary artery or graft as the drug delivery balloon intervention.
Your 2025 Coding Remains at Risk: These Are NOT All the Tips and Tricks Necessary for Cardiology Success.

With every dollar of reimbursement counting more than ever in the face of payment decline and complex new rules, it’s imperative to make sure your CPT® coding is correct and compliant. Master more cardiology coding topics and break down the complexity with our Cardiology All Access Pass.  Find the right subscription and resource tailored to your needs today to make every member of your team successful with 2025 coding.

Facebook
Twitter
LinkedIn

Bryan Nordley

Bryan Nordley is a seasoned professional writer, strategist, and researcher with over a decade’s worth of combined experience. Bryan launched his professional health writing career at the University of British Columbia’s Faculty of Medicine, one of the top 30 faculty of medicine programs in the world, working under the School of Public Health as a communications assistant. From there, he expanded his expertise and knowledge into private healthcare and podiatry before taking the role of healthcare writer at MedLearn Media. Bryan is the lead writer for the MedLearn Publishing brand previously producing both the acclaimed radiology and laboratory compliance manager newsletter products, while currently writing the compliance questions of the week which reach over 10,000 subscribers, creating the MedLearn Publishing Insights blogs and collaborating with operations and nationally renowned subject matter experts, in addition to serving as an editor for a variety of MedLearn publications along with marketing initiatives. Bryan continues to keep his pulse on the latest healthcare industry news, analyzing and reporting with strategic insight.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24